fr   en
Agreement

Tableaux synoptiques (en anglais)


Parcourir par date
Rechercher par mot clé
Date: 2010-09-10
Biotech partner: Galapagos (Belgium) Genentech (USA)
Type of agreement: * R&D
* other
Compound: drug discovery programs that utilize Argenta's expertise to discover new chemical entities acting against undisclosed drug targets defined by Genentech.
Nature of the agreement: Argenta, a service division of Galapagos, has signed a contract extension with Genentech, Inc.. The extended agreement expands the portfolio of projects which are in collaboration with Genentech and allows Genentech to place projects directly into Galapagos' other service division, BioFocus.
The current agreement covers a number of drug discovery programs that utilize Argenta's expertise in computer-aided drug design (CADD), medicinal chemistry, and in vitro biology and screening to discover new chemical entities acting against undisclosed drug targets defined by Genentech. Under the amendment announced today, BioFocus will provide Genentech with integrated medicinal chemistry, in vitro biology and ADME services.



Go back to previous page